Australia’s Healius on Tuesday said private equity firm Partners had offered to acquire the medical center operator for A$2.12 billion ($1.40 billion).
The Swiss private equity firm offered A$3.40 per share in cash, a 23.2% premium to Healius’ last closing price.
A filing earlier in the day showed Partners bought out China’s Jangh’s 15.9% majority stake in Healius.
Jangho had previously offered to buyout Healius for A$1.7 billion or A$3.25 per share, which was rejected by the Sydney-based company, saying it was “opportunistic” and fundamentally undervalued the company.
The company said it has not yet formed a view on Partners’ offer, adding that it was also subject to six weeks of due diligence.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google Faces DOJ Antitrust Trial, Publishers Watch Closely for Impact on Ad Market
Sep 9, 2024 by
CPI
India Moves to Challenge Big Tech Power in Digital Markets
Sep 9, 2024 by
CPI
US Tightens Grip on AI: New Reporting Rules for Developers and Cloud Providers
Sep 9, 2024 by
CPI
EU Court to Decide Apple’s €13bn Tax Battle
Sep 9, 2024 by
CPI
Google Lawyer Kevin Yingling Joins Freshfields Amid Antitrust Fight
Sep 9, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
CPI
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
CPI
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
CPI
The Cost of Making COFECE Disappear
Sep 3, 2024 by
CPI